Clinical Trials Browser

Phase 2 × tagraxofusp × 90 days × Clear all

NCT06456463 2026-03-09

TRILLIUM

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04216524 2026-03-04

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Phase 2 Recruiting

Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT05442216 2026-01-23

TAGALONG

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute